Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
- 14 June 2012
- journal article
- research article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 13 (7), 734-742
- https://doi.org/10.1016/s1470-2045(12)70226-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Breast-Cancer Adjuvant Therapy with Zoledronic AcidNew England Journal of Medicine, 2011
- Bone turnover across the menopause transitionAnnals of the New York Academy of Sciences, 2010
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast CancerNew England Journal of Medicine, 2009
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Inhibin Suppresses and Activin Stimulates Osteoblastogenesis and Osteoclastogenesis in Murine Bone Marrow CulturesEndocrinology, 2002
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Effect of systemic adjuvant treatment on first sites of breast cancer relapseThe Lancet, 1994
- BisphosphonatesDrugs, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958